Video above: COVID-19 vaccine reactions ‘normal,’ surgeon general saysNovavax on Monday announced the start of the Phase 3 trial of its COVID-19 vaccine in the United States and Mexico. It is the fifth company to launch a large-scale trial of a coronavirus vaccine in the United States.The trial for the vaccine candidate, known as NVX-CoV2373, will evaluate safety, efficacy and immune response in up to